Article
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Jun 2009
Maron Eduard, Tammiste Anu, Kallassalu Kristi, Eller Triin, Vasar Veiko, Nutt David J, Metspalu Andres
Abstract excerpt
Several studies and meta-analyses have implicated a polymorphism in the promoter region of the serotonin transporter (5-HTT) gene, 5-HTTLPR in treatment outcomes of selective serotonin re-uptake inhibitors in patients with major depression. In this study we investigated the impact of 5-HTTLPR and a functional SNP rs25531 on the treatment outcomes to escitalopram in depressive patients. The study sample consisted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
